D

Bausch + Lomb Corporation BLCO.TO

TSX
Recommendation
Dividend Power Score
Day's Range
$28.49$28.80
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

BLCO.TO Rating

Reward
Risk

BLCO.TO Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

BLCO.TO Company Overview

Bausch + Lomb Corporation is a global eye health company focused on vision care, ophthalmic pharmaceuticals, surgical products, and consumer eye health solutions. The company operates across the broader healthcare and medical technology industries, serving patients, eye care professionals, hospitals, ambulatory surgery centers, and retail consumers. Its primary revenue drivers include contact lenses, lens care products, prescription ophthalmic medicines, over-the-counter eye care products, cataract surgery equipment, and vitreoretinal surgical systems. The company competes with other major ophthalmology and vision care firms through a diversified product portfolio spanning both medical devices and pharmaceuticals.

The company traces its origins to 1853 when it was founded in Rochester, New York by John Jacob Bausch and Henry Lomb. Over time, it evolved from an optical goods manufacturer into a diversified eye health company with global operations. Bausch + Lomb underwent multiple ownership changes, including acquisition by Valeant Pharmaceuticals (later renamed Bausch Health Companies). In 2022, Bausch + Lomb Corporation returned to the public markets through an initial public offering while maintaining operational ties to Bausch Health. The company positions itself through broad product diversification, established ophthalmology relationships, a large international distribution footprint, and a recognized brand in eye care supported by product development and regulatory expertise.

Data compiled by narrative technology. May contain errors.
Sector

BLCO.TO Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

BLCO.TO Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

BLCO.TO Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

BLCO.TO Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--

BLCO.TO Valuation

Market Cap
Market Cap Rank
#2,899
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

BLCO.TO Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

BLCO.TO Corporate Info

Phone Number
905 695 7700
Address
520 Applewood Crescent
Vaughan, ON L4K 4B4
Country
Year Founded

BLCO.TO Filings

Filing Date
Wednesday, October 28, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 15 and 19 (est)

BLCO.TO Headlines

11/17/2026 - Zacks Investment Research
11/13/2026 - Zacks Investment Research
11/11/2026 - Zacks Investment Research
11/9/2026 - Zacks Investment Research
11/5/2026 - Zacks Investment Research